Blog
RSS FeedPosted by Michael Wonder on 06 Feb 2024
Updates on NICE and SMC collaboration on MTA for cystic fibrosis
1 February 2024 - On 19 December 2023, we advised that NICE would be liaising with key stakeholders to determine ...
Posted by Michael Wonder on 25 Jan 2024
PHARMAC joins global health technology assessment network
25 January 2024 - PHARMAC has joined the International Network of Agencies for Health Technology Assessment (INAHTA) - a network ...
Posted by Michael Wonder on 03 Jan 2024
MHRA’s new international recognition procedure goes live from 1 January 2024
2 January 2024 - In partnership with other global regulators, the international recognition procedure is expected to further help bring life-saving ...
Posted by Michael Wonder on 10 Nov 2023
MHRA joins global regulatory partners in celebrating ten years of international medicines regulatory cooperation
9 November 2023 - As a founding member and former chair of the International Coalition of Medicines Regulatory Authorities (ICMRA), the MHRA ...
Posted by Michael Wonder on 02 Nov 2023
FDA notes “continued growth” of Orbis collaborative review program, adds EMA as observer
1 November 2023 - There has been “continued growth” in the number of applications submitted to Project Orbis, and the ...
Posted by Michael Wonder on 20 Oct 2023
Ethical and legal considerations in social media research for health technology assessment: conclusions from a scoping review
20 October 2023 - The objective was to identify and describe the published guidance and current academic discourse of ethical issues ...
Posted by Michael Wonder on 20 Sep 2023
International HTA collaboration expands
20 September 2023 - The international collaboration between six health technology assessment bodies from across the UK, Australia and Canada ...
Posted by Michael Wonder on 12 Sep 2023
MHRA’s new International Recognition Procedure: how does it shape up?
12 September 2023 - The field of life sciences and medicine development has become increasingly global. Multinational firms must make informed ...
Posted by Michael Wonder on 24 Aug 2023
International heath technology assessment collaboration expands
24 August 2023 - The international collaboration between six health technology assessment bodies from across the UK, Australia and Canada has ...
Posted by Michael Wonder on 10 Aug 2023
Patient and citizen participation at the organisational level in health technology assessment: an exploratory study in five jurisdictions
8 August 2023 - While patient participation in individual health technology assessments has been frequently described in the literature, patient and ...
Posted by Michael Wonder on 28 Jul 2023
CDER collaborates with global regulators on pharmaceutical quality assessments and inspections
28 July 2023 - The FDA and the EMA recently completed the first collaborative assessment of a proposed post-approval change ...
Posted by Michael Wonder on 20 Jul 2023
PHARMAC joins international collaboration to advance use of health technology assessments
20 July 2023 - PHARMAC has joined an international collaboration of government health technology assessment agencies. ...
Posted by Michael Wonder on 14 May 2023
The FINOSE collaboration is extended and strengthened by the entry of the Danish Medicines Council
11 May 2023 - On 10 May 2023, the Nordic HTA collaboration FINOSE was extended for another three years and the ...
Posted by Michael Wonder on 24 Apr 2023
NICE collaborates with international partner agencies to streamline the confidential marking process
24 April 2023 - NICE, the Canadian Agency for Drugs and Technologies in Health and the US’s Institute for Clinical and ...
Posted by Michael Wonder on 05 Apr 2023
Faster UK drug approvals by relying on other countries
5 April 2023 - Safety and efficacy must be prioritised ahead of speed. ...